Michael D. Shmerling's most recent trade in Healthstream Inc was a trade of 3,241 Common Stock Holding done . Disclosure was reported to the exchange on May 25, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2023 | 3,241 | 133,609 (0%) | 0% | 0 | Common Stock Holding | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2023 | 2,297 | 0 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2023 | 944 | 0 | - | - | Restricted Share Units | |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 529 | 28,671 | - | - | Phantom Stock | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2023 | 3,037 | 130,368 (0%) | 0% | 0 | Common Stock Holding | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2023 | 1,148 | 2,297 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2023 | 946 | 0 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2023 | 943 | 944 | - | - | Restricted Share Units | |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 393 | 27,780 | - | - | Phantom Stock | |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 24.83 per share. | 12 Dec 2022 | 227 | 127,331 (0%) | 0% | 24.8 | 5,636 | Common Stock Holding |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 456 | 27,387 | - | - | Phantom Stock | |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 22.50 per share. | 12 Sep 2022 | 417 | 127,104 (0%) | 0% | 22.5 | 9,383 | Common Stock Holding |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 489 | 26,743 | - | - | Phantom Stock | |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 21.22 per share. | 24 Jun 2022 | 236 | 126,687 (0%) | 0% | 21.2 | 5,008 | Common Stock Holding |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 20.12 per share. | 10 Jun 2022 | 528 | 126,451 (0%) | 0% | 20.1 | 10,623 | Common Stock Holding |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 1,616 | 165,178 (0%) | 0% | 0 | Common Stock | |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 457 | 26,055 | - | - | Phantom Stock | |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 3,445 | 3,445 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2022 | 2,675 | 125,923 (0%) | 0% | 0 | Common Stock Holding | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2022 | 945 | 946 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2022 | 943 | 1,887 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2022 | 787 | 0 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 20.12 per share. | 10 Mar 2022 | 466 | 123,248 (0%) | 0% | 20.1 | 9,376 | Common Stock Holding |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 24.61 per share. | 10 Dec 2021 | 229 | 122,782 (0%) | 0% | 24.6 | 5,636 | Common Stock Holding |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 461 | 24,824 | - | - | Phantom Stock | |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 29.93 per share. | 10 Sep 2021 | 313 | 122,553 (0%) | 0% | 29.9 | 9,368 | Common Stock |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 426 | 24,215 | - | - | Phantom Stock | |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 26.49 per share. | 10 Jun 2021 | 401 | 122,240 (0%) | 0% | 26.5 | 10,622 | Common Stock |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 1,555 | 163,562 (0%) | 0% | 0 | Common Stock | |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 410 | 23,658 | - | - | Phantom Stock | |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 2,830 | 2,830 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 2,610 | 121,839 (0%) | 0% | 0 | Common Stock | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 945 | 1,891 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 879 | 0 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2021 | 786 | 787 | - | - | Restricted Share Units | |
Healthstream Inc | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 23.94 per share. | 10 Mar 2021 | 392 | 119,229 (0%) | 0% | 23.9 | 9,384 | Common Stock |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 651 | 22,978 | - | - | Phantom Stock | |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 656 | 22,327 | - | - | Phantom Stock | |
Renasant Corp. | Michael D. Shmerling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 725 | 21,463 | - | - | Phantom Stock |